Vyant Bio Announces Investor Conference Call and Webcast for the Third Quarter 2021
09 nov. 2021 09h15 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Vyant Bio Announces Robert T. Fremeau, Jr. Ph.D. as Chief Scientific Officer
26 oct. 2021 08h00 HE
|
Vyant Bio, Inc.
Cherry Hill, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company identifying small and large molecule...
MASORI THERAPEUTICS AND VYANT BIO, INC. ANNOUNCE NEW PARTNERSHIP
19 oct. 2021 08h30 HE
|
Vyant Bio, Inc.
Engagement will combine MASORI’s global platforms and commercial experience in Japan to identify partnerships that leverage Vyant Bio’s advanced analytics and complex human-derived biology to drive...
MASORI THERAPEUTICS AND VYANT BIO, INC. ANNOUNCE NEW PARTNERSHIP
19 oct. 2021 08h30 HE
|
Vyant Bio, Inc.
Engagement will combine MASORI’s global platforms and commercial experience in Japan to identify partnerships that leverage Vyant Bio’s advanced analytics and complex human-derived biology to drive...
Vyant Bio Reports Second Quarter 2021 Results and Provides Strategic Business Updates
16 août 2021 16h01 HE
|
Vyant Bio, Inc.
Strategic Highlights Received an issued US Patent titled “High Throughput Optical Assay of Human Mixed Cell Population Spheroids” by the United States...
Vyant Bio Announces Investor Conference Call and Webcast for Second Quarter 2021
11 août 2021 09h00 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), an emerging global drug discovery company, is rapidly identifying small and large...
Vyant Bio Announces Issuance of Key Patent for High-Throughput Optical Assay of Human Mixed Cell Population Spheroids
13 juil. 2021 08h20 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., July 13, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, the “Company”) (Nasdaq: VYNT), an emerging leader in novel drug discovery technologies, announced today that its...
Vyant Bio to Present at BioNJ’s 11th Annual BioPartnering Conference
11 mai 2021 16h36 HE
|
Vyant Bio, Inc.
CHERRY HILL, N.J., May 11, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio”, “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and...